BioArctic AB (publ) - Asset Resilience Ratio

Latest as of March 2026: 30.98%

BioArctic AB (publ) (BIOA-B) has an Asset Resilience Ratio of 30.98% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BioArctic AB (publ) short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Skr829.92 Million

≈ $89.31 Million USD Cash + Short-term Investments

Total Assets

Skr2.68 Billion

≈ $288.33 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how BioArctic AB (publ)'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see BIOA-B asset base.

Liquid Assets Composition Over Time

This chart breaks down BioArctic AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read BioArctic AB (publ) debt and liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr829.92 Million	30.98%
Total Liquid Assets	Skr829.92 Million	30.98%

Asset Resilience Insights

Very High Liquidity: BioArctic AB (publ) maintains exceptional liquid asset reserves at 30.98% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

BioArctic AB (publ) Industry Peers by Asset Resilience Ratio

Compare BioArctic AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for BioArctic AB (publ) (2017–2025)

The table below shows the annual Asset Resilience Ratio data for BioArctic AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	85.06%	Skr2.19 Billion ≈ $235.73 Million	Skr2.58 Billion ≈ $277.14 Million	+14.99pp
2024-12-31	70.07%	Skr778.92 Million ≈ $83.82 Million	Skr1.11 Billion ≈ $119.63 Million	+27.91pp
2023-12-31	42.16%	Skr500.00 Million ≈ $53.81 Million	Skr1.19 Billion ≈ $127.64 Million	-52.35pp
2021-12-31	94.51%	Skr848.40 Million ≈ $91.30 Million	Skr897.73 Million ≈ $96.61 Million	-0.70pp
2020-12-31	95.20%	Skr999.94 Million ≈ $107.61 Million	Skr1.05 Billion ≈ $113.03 Million	+1.17pp
2019-12-31	94.04%	Skr1.11 Billion ≈ $119.75 Million	Skr1.18 Billion ≈ $127.35 Million	+28.19pp
2018-12-31	65.85%	Skr917.31 Million ≈ $98.72 Million	Skr1.39 Billion ≈ $149.91 Million	-31.51pp
2017-12-31	97.36%	Skr1.11 Billion ≈ $119.49 Million	Skr1.14 Billion ≈ $122.73 Million	--

pp = percentage points

About BioArctic AB (publ)

ST:BIOA-B Sweden Biotechnology

Market Cap

$2.54 Billion

Skr23.59 Billion SEK

Market Cap Rank

#5406 Global

#73 in Sweden

Share Price

Skr317.40

Change (1 day)

-2.46%

52-Week Range

Skr263.60 - Skr364.40

All Time High

Skr377.80